ArticleFrontiers in pharmacology2026

Isoalantolactone inhibits pancreatic ductal adenocarcinoma progression via direct targeting of NLRP3-mediated inflammation-angiogenesis axis.

Ying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.